By now most people know that GLP-1 (glucagon-like peptide agonist) drugs activate receptors of the intestinal GLP-1 hormone, causing the stomach to empty more slowly after eating and signal to the brain that its full
Much like checking only the speed of a car without looking at fuel or engine health, relying on Read More Stopping GLP-1 Therapy: New Data Highlight the Challenge of Weight Regain Mar 27, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity 1,534 views Have you ever wondered why weight seems to come back so quickly after stopping a medication that once worked so well
As one analyst noted, it signals Novo is taking a more aggressive stance rather than letting Lilly control the narrative in this fast-growing category
AIDS 29:433442 Younas M, Psomas C, Reynes J, Corbeau P (2016) Immune activation in the course of HIV-1 infection: causes, phenotypes and persistence under therapy